Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor

  1. Martins, A.S.
  2. Mackintosh, C.
  3. Herrero Martín, D.
  4. Campos, M.
  5. Hernández, T.
  6. Ordóñez, J.-L.
  7. De Alava, E.
Aldizkaria:
Clinical Cancer Research

ISSN: 1078-0432

Argitalpen urtea: 2006

Alea: 12

Zenbakia: 11 I

Orrialdeak: 3532-3540

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-05-1778 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus